Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$112M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$79.6M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$41.3M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$24.6M |
| 5 |
Global Payments
GPN
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$104M |
| 2 |
IHS
IHS INC CL-A COM STK
IHS
|
+$30.4M |
| 3 |
Pfizer
PFE
|
+$25.8M |
| 4 |
H&R Block
HRB
|
+$23.6M |
| 5 |
Quest Diagnostics
DGX
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.51% |
| 2 | Healthcare | 11.03% |
| 3 | Industrials | 10.52% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Financials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GK
526
DELISTED
G&K Services Inc
GK
| $508K | 0.02% |
+9,750
| New | +$530K |
|
527
Edison International
EIX
$27.5B
| $507K | 0.02% |
8,728
-11,341
| -57% | -$635K |
|
528
AMC Global Media
AMCX
$511M
| $506K | 0.02% |
+8,227
| New | +$526K |
|
529
LiveRamp
RAMP
$2.28B
| $506K | 0.02% |
23,333
+11,811
| +103% | +$305K |
|
|
BGC
530
DELISTED
General Cable Corporation
BGC
| $506K | 0.02% |
19,700
-17,872
| -48% | -$449K |
|
531
Hancock Whitney
HWC
$6.05B
| $505K | 0.02% |
14,287
+4,287
| +43% | +$148K |
|
532
Ecolab
ECL
$78.9B
| $504K | 0.02% |
+4,524
| New | +$485K |
|
533
Heron Therapeutics
HRTX
$60.4M
| $503K | 0.02% |
40,800
+15,801
| +63% | +$189K |
|
534
Palo Alto Networks
PANW
$292B
| $503K | 0.02% |
+35,982
| New | +$420K |
|
535
Cimpress
CMPR
$2.13B
| $502K | 0.02% |
12,400
+700
| +6% | +$30.4K |
|
536
Goldgroup Mining
GORO
$240M
| $502K | 0.02% |
99,119
-15,034
| -13% | -$68.6K |
|
|
GXP
537
DELISTED
Great Plains Energy Incorporated
GXP
| $500K | 0.02% |
18,600
+5,000
| +37% | +$131K |
|
538
Myriad Genetics
MYGN
$306M
| $499K | 0.02% |
12,833
+5,928
| +86% | +$221K |
|
539
Koppers
KOP
$855M
| $497K | 0.02% |
12,997
+4,404
| +51% | +$173K |
|
540
Royal Caribbean
RCL
$78.1B
| $495K | 0.02% |
8,900
+2,300
| +35% | +$124K |
|
|
PIKE
541
DELISTED
PIKE CORPORATION COM STK (NC)
PIKE
| $495K | 0.02% |
55,280
+39,802
| +257% | +$372K |
|
|
542
Quest Diagnostics
DGX
$27B
| $493K | 0.02% |
8,400
-397,667
| -98% | -$23.3M |
|
543
Oshkosh
OSK
$9.7B
| $493K | 0.02% |
+8,878
| New | +$491K |
|
|
FRED
544
DELISTED
Fred's Inc
FRED
| $492K | 0.02% |
+32,200
| New | +$539K |
|
545
American Electric Power
AEP
$65.8B
| $491K | 0.02% |
8,800
-11,827
| -57% | -$624K |
|
|
SAPE
546
DELISTED
SAPIENT CORP
SAPE
| $491K | 0.02% |
30,200
+10,231
| +51% | +$168K |
|
|
AGN
547
DELISTED
Allergan Inc
AGN
| $491K | 0.02% |
2,900
-7,087
| -71% | -$1.1M |
|
548
Sturm, Ruger & Co
RGR
$624M
| $490K | 0.02% |
8,300
-1,499
| -15% | -$93.8K |
|
|
PDLI
549
DELISTED
PDL BioPharma, Inc.
PDLI
| $490K | 0.02% |
50,600
-31,800
| -39% | -$283K |
|
550
ConocoPhillips
COP
$162B
| $489K | 0.02% |
5,700
+400
| +8% | +$31.2K |
|
Similar funds
Paul Tudor Jones's Q2 2014 Portfolio in Review
As of Q2 2014, Paul Tudor Jones held 1,510 positions worth $2.61B, up 11% from $2.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Paul Tudor Jones deployed $161M of net new capital in Q2 2014, opening 336 new positions and adding to 390 existing holdings. Its largest new stake was Apple: 5,248,200 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Pfizer, an estimated $25.8M trimmed.
- Paul Tudor Jones's largest Q2 2014 buy was Apple: 5,248,200 shares worth $122M.
- Paul Tudor Jones added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $79.6M increase.
- Paul Tudor Jones's biggest Q2 2014 reduction was Pfizer, cutting an estimated $25.8M.
- Paul Tudor Jones fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2014, selling an estimated $104M.
- Paul Tudor Jones's ten largest holdings make up 46% of its $2.61B portfolio in Q2 2014.
- Paul Tudor Jones opened 336 new positions and closed 367 in Q2 2014.
- Paul Tudor Jones's portfolio value rose 11% quarter-over-quarter to $2.61B.
Based on Tudor Investment Corp's 13F filing for Q2 2014, filed 14 Aug 2014.